The success of China-Europe rail freight raises the question of its subsidy policy. In 2022, an adjustment seems more likely than an outright end to subsidies.
The growing Asian markets have proven to be of utmost interest for the pharmaceutical industry. At the same time, logistics providers are facing diverse market conditions depending on the maturity of the market and its political system.